What Is Non Invasive Prenatal Screening?

Learn what non invasive prenatal screening (NIPT) is in 2026. Understand cell-free DNA testing for chromosomal conditions. US guide to ordering a panel.

Non invasive prenatal screening (NIPS) is a blood test that analyzes cell-free DNA fragments from the placenta to screen for common chromosomal abnormalities such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). This cell-free DNA test, often called NIPT (non-invasive prenatal testing), can be performed as early as 10 weeks of pregnancy and poses no risk of miscarriage because it requires only a maternal blood draw—no invasive procedure like amniocentesis or chorionic villus sampling. In the United States, NIPT has become a standard first-trimester screening option for expectant parents seeking reliable, early information about their baby’s chromosomes without the risks associated with diagnostic tests.

How Non Invasive Prenatal Screening Works

Cell-Free DNA in Maternal Blood

During pregnancy, small fragments of DNA from the placenta (which typically reflects the fetal genetic makeup) enter the mother’s bloodstream. A blood sample from the pregnant person is taken, and the cell-free DNA is isolated and sequenced. Advanced algorithms count the number of copies of each chromosome; an excess or deficit indicates a possible chromosomal condition. The test does not replace diagnostic procedures but offers a high-accuracy screen.

Fetal Fraction and Timing

The proportion of cell-free DNA that comes from the placenta is called the fetal fraction. A minimum fetal fraction of 4% is usually needed for reliable results. This is typically reached by 10 weeks gestation. Factors such as maternal weight, multiple pregnancies, and certain medical conditions can affect fetal fraction, which is why your provider may recommend repeating the test or proceeding to diagnostic testing if results are unclear.

What Conditions Does NIPT Screen For?

Non invasive prenatal screening primarily targets the most common trisomies. Some expanded panels also screen for sex chromosome aneuploidies and certain microdeletions. The following table summarizes the conditions typically included:

Note: Accuracy percentages are approximate population-based figures and not a guarantee for any individual result.

Non Invasive Prenatal Screening vs. Other Prenatal Tests

It is important to understand how NIPT compares to other options available in the US:

• First-trimester screening (ultrasound + blood biomarkers): lower detection rate for Down syndrome (~80-85%) and higher false-positive rate than NIPT.
• Quad screen (second-trimester blood test): screens for neural tube defects as well as aneuploidies but has lower sensitivity than NIPT.
• Integrated screening: combines first- and second-trimester results; still less accurate than NIPT for trisomies.
• Chorionic villus sampling (CVS) and amniocentesis: diagnostic tests that can confirm a chromosomal condition but carry a small risk of miscarriage (0.1–0.5%). NIPT is a screening test, not diagnostic, so any positive result should be followed up with CVS or amniocentesis for confirmation.
• Carrier screening: a separate test that identifies whether parents carry genes for inherited disorders such as cystic fibrosis, spinal muscular atrophy, or fragile X syndrome. NIPT does not replace carrier screening.

Who Should Consider Non Invasive Prenatal Screening?

The American College of Obstetricians and Gynecologists recommends that all pregnant individuals be offered NIPT, regardless of maternal age or prior risk factors. Many US insurance plans cover the test for women over 35 or those with certain ultrasound findings, but increasingly NIPT is offered as a routine option. If you have a family history of chromosomal abnormalities or are simply seeking the most accurate screening available, NIPT is a valuable tool.

Accuracy and Limitations of NIPT

Although NIPT boasts high detection rates, it is not perfect. False positives and false negatives can occur, especially for rare conditions or when fetal fraction is low. A positive NIPT result must be confirmed with a diagnostic test such as chorionic villus sampling or amniocentesis, and it is essential to work with a genetic counselor to understand the results and next steps. Additionally, NIPT does not screen for all genetic disorders, structural abnormalities (like spina bifida), or conditions not caused by extra or missing chromosomes. It is one component of a comprehensive prenatal care plan that may also include first-trimester screening, ultrasound, and carrier screening.

If you are considering non invasive prenatal screening, your healthcare provider can help you choose the right test for your situation. For those who prefer the convenience of online ordering, you can order a comprehensive prenatal screening panel online and receive confidential results quickly. order a prenatal screening panel online to gain early insights into your pregnancy.